Dimaymay, Jenifer .

HRN: 06-29-02  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/23/2024
07/30/2024
IV
500 Mg
Q8
UTI X 3 Doses
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Urinary TractReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: